Press Releases
GI Dynamics Receives ISO Certification and European CE Mark Approval for the EndoBarrier™ Gastrointestinal Liner System
Lexington, MA, January 7, 2009 – GI Dynamics, a medical device company pioneering the development of new approaches to treat obesity and metabolic disorders, today announced that it has received ISO 13485:2003 certification for the company’s Lexington facility. The company has also received...
read moreNew Data in Journal Obesity Demonstrate that a Noninvasive, Removable Medical Device Results in Substantial Weight Loss and Glucose Normalization in a Preclinical Model of Obesity
Data Support Weight Loss and Glucose Results Observed in Clinical Trials of EndoBarrier™; Study Recognized by Obesity Society at 2008 Annual Meeting LEXINGTON, Mass., November 18, 2008 – GI Dynamics, a medical device company pioneering the development of new approaches to treat obesity and type 2...
read moreGI Dynamics Announces Promising Multi-Center Safety and Efficacy Data of EndoBarrier™ Gastrointestinal Liner for Pre-Surgical Weight Loss
New Clinical Data Presented at IFSO Show Excellent Short Term Weight Loss Results in Morbidly Obese Patients Buenos Aires, Argentina, September 26, 2008 – GI Dynamics, a medical device company pioneering the development of new approaches to treat obesity and metabolic disorders, today announced...
read moreGI Dynamics to Present Data from Clinical Weight Loss Study of EndoBarrier™ Gastrointestinal Liner in Morbidly Obese Patients at the International Federation for Surgery of Obesity and Metabolic Disorders (IFSO) 13th World Congress
(IFSO) 13th World Congress LEXINGTON, Mass., September 19, 2008 – GI Dynamics, a medical device company pioneering the development of new approaches to treating metabolic disorders, today announced that new data regarding EndoBarrier™, its novel, noninvasive device currently in clinical trials to...
read moreGI Dynamics Announces Data Demonstrating Immediate and Sustained Reduction in HbA1c in Patients with Type 2 Diabetes Using EndoBarrier™ Gastrointestinal Liner
Compelling Clinical Data Highlighted at First World Congress on Interventional Therapies for Type 2 Diabetes Show Improved Glycemic Control and Weight Reduction in Uncontrolled Diabetics NEW YORK, NY, September 16, 2008 – GI Dynamics, a medical device company pioneering the development of new...
read moreData from Clinical Trial of EndoBarrier™ Gastrointestinal Liner in Patients with Type 2 Diabetes to be Presented at the First World Congress on Interventional Therapies for Type 2 Diabetes in New York
LEXINGTON, Mass., September 9, 2008 – GI Dynamics, a medical device company pioneering the development of new approaches to treating metabolic disorders, today announced that new data regarding EndoBarrier™, its novel, noninvasive device currently in clinical trials to treat obesity and type 2...
read moreVideos
How EndoBarrier Works
EndoBarrier: Non-surgical Treatment for Patients with Type 2 Diabetes and …
Maintenance of Efficacy after EndoBarrier
UK First NHS EndoBarrier Service – Dr. Bob Ryder June …
BBC News Item
EndoBarrier treatment for diabetes & obesity following 1 year results …
